Skip to main content

Novel vascular-like BBB-on-a-chip

Project description

BBB-on-a-chip to accelerate drug discovery

The pharmaceutical industry and patients desperate for new drugs to treat their illnesses can benefit greatly from improvements in the drug development process. There is a growing need for safer and more biologically relevant models for drug screening. The inability to properly test drugs and treatments to diseases such as Alzheimer’s Disease is a major problem. The EU-funded NOVACHIP project is working on a solution. It is developing a scalable 3D Blood-Brain-Barrier in vitro model (BBB-on-a-chip) to provide a higher level of biological relevance than current in vitro models. Such a system would represent a major breakthrough for the pharmaceutical industry generating therapies for a variety of neurological disorders.

Host institution

THE UNIVERSITY OF NOTTINGHAM
Net EU contribution
€ 149 951,00
Address
University Park
NG7 2RD Nottingham
United Kingdom

See on map

Region
East Midlands (England) Derbyshire and Nottinghamshire Nottingham
Activity type
Higher or Secondary Education Establishments
Other funding
€ 149 951,00

Beneficiaries (1)

THE UNIVERSITY OF NOTTINGHAM
United Kingdom
Net EU contribution
€ 149 951,00
Address
University Park
NG7 2RD Nottingham

See on map

Region
East Midlands (England) Derbyshire and Nottinghamshire Nottingham
Activity type
Higher or Secondary Education Establishments
Other funding
€ 149 951,00